Pascal Minne, Director, 10% Owner at LEXICON PHARMACEUTICALS, INC. (LXRX), bought 94,346 shares at $13.45 ($1.3M) on 2018-06-19, disclosed to the SEC on 2018-06-21.
Open-market purchase of $1.3M LXRX by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.45 | 8,982 | $121K | 9.6% |
| 2 | $13.45 | 8,982 | $121K | 9.6% |
| 3 | $13.28 | 12,391 | $165K | 13.1% |
| 4 | $13.28 | 12,391 | $165K | 13.1% |
| 5 | $13.27 | 51,600 | $685K | 54.5% |
| Total | $13.31 avg | 94,346 |
| $1.3M |
| 100% |
| Filing → |
| LXRX | BUY | 2014-11-26 | $150.7M | — | Filing → |
| WTW | BUY | 2014-08-06 | $5.6M | — | Filing → |